Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology

• Главные авторы: Feng Xu (Автор), Mei Zhang (Автор), Hongmei Wu (Автор), Yuanmin Wang (Автор), Ye Yang (Автор), Xiangpei Wang (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Context Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action.Objective Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes.Materials...